Apolipoprotein E Promotes Immune Suppression in Pancreatic Cancer through NF-κB–Mediated Production of CXCL1-Reference-Cited by-同舟云学术

Apolipoprotein E Promotes Immune Suppression in Pancreatic Cancer through NF-κB–Mediated Production of CXCL1

Published:2021-05-28 Issue:16 Volume:81 Page:4305-4318
ISSN:0008-5472
Container-title:Cancer Research
language:en
Short-container-title:Cancer Res

Author:

Kemp Samantha B.,Carpenter Eileen S.,Steele Nina G.,Donahue Katelyn L.^ORCID,Nwosu Zeribe C.^ORCID,Pacheco Amanda^ORCID,Velez-Delgado Ashley,Menjivar Rosa E.,Lima Fatima,The Stephanie,Espinoza Carlos E.,Brown Kristee,Long Daniel,Lyssiotis Costas A.^ORCID,Rao Arvind^ORCID,Zhang Yaqing,Pasca di Magliano Marina^ORCID,Crawford Howard C.^ORCID

Funder

NIH

University of Michigan Cancer Center Support Grant

NCI

Michigan Postdoctoral Pioneer Program

University of Michigan Medical School

American College of Gastroenterology Clinical Research Award

American Cancer Society Postdoctoral Award

American Cancer Society

Publisher

American Association for Cancer Research (AACR)

Subject

Cancer Research,Oncology

Cited by 105 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Unveiling the resistance to therapies in pancreatic ductal adenocarcinoma;Drug Resistance Updates;2024-11

2. IDO1 inhibitors are synergistic with CXCL10 agonists in inhibiting colon cancer growth;Biomedicine & Pharmacotherapy;2024-10

3. Barriers and opportunities in pancreatic cancer immunotherapy;npj Precision Oncology;2024-09-12

4. Decoding multicellular niche formation in the tumour microenvironment from nonspatial single-cell expression data;2024-08-21

5. A tumour‐associated macrophage‐based signature for deciphering prognosis and immunotherapy response in prostate cancer;IET Systems Biology;2024-08-13